ClinicalTrials.gg
Not yet recruitingNCT06283771Updated Sep 9, 2025

The Effect of Warmed Socks Developed as Wearable Technology on Hypothermia, Thermal Comfort Perception and Shivering

An interventional study of Heated socks to be developed with wearable technology in Wearable Technology, Hypothermia and Shivering, sponsored by Tarsus University. Not yet recruiting. Per ClinicalTrials.gov, last updated 2025-09-09.

Sponsored by Tarsus University · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Sex
All
01

Study summary

In this study, it is aimed to reveal the effect of the use of heated socks to be developed as wearable technology by providing temperature control on body temperature, comfort perception level and shivering development in healthy volunteers and this purpose constitutes the unique value of the project. The research was planned as a prospective, two-arm (1:1), randomized controlled, double-blind study. The population of the study will consist of 4th year nursing students consisting of an average of 250 people who will enroll in the fall semester of the 2024-2025 academic year. As a result of the power analysis performed in the G*Power program, the sample will consist of 70 healthy volunteers, at least 35 in each group. In the study, data will be collected with the "Descriptive Characteristics Form" and "Hypothermia Monitoring Form (Shivering Level Diagnosis Form and Temperature Comfort Perception Scale)" which includes the descriptive information of healthy volunteers. Healthy volunteers will fill out the "Introductory Characteristics Form" and "Hypothermia Monitoring Form" before being taken to the Faculty of Nursing Skills Laboratory for the application. Before the volunteers are taken to the single rooms in the laboratory, the environment will be cooled for 30 minutes with the air conditioner in the room so that the temperature is 21oC. The study group will wear socks developed with wearable technology and the control group will wear socks with the same appearance. The healthy volunteer will be asked to lie motionless on the bed for 60 minutes in a single room. Body temperature (with Braun tympanic thermometer), shivering level and temperature comfort perception will be recorded on the "Hypothermia Monitoring Form" when all healthy volunteers are taken to the Skills Laboratory, at 15 minutes, 30 minutes and 60 minutes, and when they leave the laboratory. The research data will be analyzed in a computer environment. Descriptive variables of healthy volunteers included in the study will be expressed as mean±standard deviation and median (maximum minimum), percentage and frequency. Changes in body temperature measurements obtained after wearing socks to be developed with wearable technology, repeated measurements, analysis of variance (Repeated ANOVA) if parametric, Friedman test if non-parametric, and post-hoc test will be used in intra-group multiple comparison analysis as further analy

Read the detailed description

Increasing developments in science have led to rapid advances in health technology. One of these developments is wearable technology. Wearable devices play a key role in the field of healthcare, especially since they play an active role in providing data by monitoring changes in vital signs in real time. Textile-based sensors, electrodes and other devices are used in conjunction with wearable technological devices due to their low cost, flexibility and ease of application. Existing studies have focused on the impact of wearable technologies on positive patient outcomes in different fields. However, previously developed textile-based medical products, patents or utility model examples have not been designed to prevent hypothermia in healthy adults by providing temperature control. In this study, it is aimed to reveal the effect of the use of heated socks to be developed as wearable technology by providing temperature control on body temperature, comfort perception level and shivering development in healthy volunteers and this purpose constitutes the unique value of the project. The research was planned as a prospective, two-arm (1:1), randomized controlled, double-blind study. The population of the study will consist of 4th year nursing students consisting of an average of 250 people who will enroll in the fall semester of the 2024-2025 academic year. As a result of the power analysis performed in the G*Power program, the sample will consist of 70 healthy volunteers, at least 35 in each group, taking into account the losses with 95% power and a maximum of 5% type error in both directions. In the study, data will be collected with the "Descriptive Characteristics Form" and "Hypothermia Monitoring Form (Shivering Level Diagnosis Form and Temperature Comfort Perception Scale)" which includes the descriptive information of healthy volunteers. Healthy volunteers will fill out the "Introductory Characteristics Form" and "Hypothermia Monitoring Form" before being taken to the Faculty of Nursing Skills Laboratory for the application. Before the volunteers are taken to the single rooms in the laboratory, the environment will be cooled for 30 minutes with the air conditioner in the room so that the temperature is 21oC. The study group will wear socks developed with wearable technology and the control group will wear socks with the same appearance. The healthy volunteer will be asked to lie motionless on the bed for 60 minutes in a single room. Body temperature (with Braun tympanic thermometer), shivering level and temperature comfort perception will be recorded on the "Hypothermia Monitoring Form" when all healthy volunteers are taken to the Skills Laboratory, at 15 minutes, 30 minutes and 60 minutes, and when they leave the laboratory. The research data will be analyzed in a computer environment. Descriptive variables of healthy volunteers included in the study will be expressed as mean±standard deviation and median (maximum minimum), percentage and frequency. Changes in body temperature measurements obtained after wearing socks to be developed with wearable technology, repeated measurements, analysis of variance (Repeated ANOVA) if parametric, Friedman test if non-parametric, and post-hoc test will be used in intra-group multiple comparison analysis as further analysis.

02

Conditions studied

  • Wearable Technology
  • Hypothermia
  • Shivering
  • Thermal Comfort Perception

Browse trials for

03

In context

Hypothermia

449 studies on the registry are indexed under Hypothermia; 54 are open to participants now.

This study's planned enrollment of 70 is close to the median of 77 across 328 interventional studies indexed under Hypothermia.

Browse Hypothermia studies →

Lead sponsor

Tarsus University is the lead sponsor of 82 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • -Written and verbal permission to participate in the study was obtained,
  • No communication problems,
  • Speaks and understands Turkish,
  • Non-hypothermic,
  • Not diagnosed with a chronic disease,
  • Not allergic to sock material,
  • No peripheral vascular disease,
  • Without a device that sends electric current into the body (pacemaker, etc.),
  • Healthy volunteers with a within normal limits (18.5-24.9 kg/m2).

Exclusion criteria

Exclusion Criteria:

  • Written and verbal permission to participate in the research could not be obtained,
  • Communication problems,
  • Speaking Turkish but not understanding it,
  • Diagnosed with a chronic disease,
  • Hypothermic,
  • Peripheral vascular disease,
  • Allergic to sock material,
  • A person with a device (pacemaker, etc.) that sends electric current into the body,
  • Healthy volunteers with a not within normal limits (\<18.5 kg/m2- >25 kg/m2)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    EXPERIMENTAL GROUP

    The study group will wear heated socks to be developed with wearable technology

    Other: Heated socks to be developed with wearable technology

  • No intervention
    CONTROL GROUP

    The control group will wear socks that look exactly the same as the heated socks developed with wearable technology worn by the study group, but with a closed heating circuit.

Interventions

  • OtherHeated socks to be developed with wearable technology

    The study group will wear heated socks to be developed with wearable technology

06

What researchers measure

Primary outcomes

  1. Body temperature

    Hypothermia Monitoring Form: It is a form in which body temperature, shivering level and temperature comfort perception of healthy volunteers are recorded. The body temperature of the healthy volunteers in the study and control groups will be measured when they are admitted to the basic skills laboratory, 15 minutes after they are admitted to the laboratory, 30 minutes after they are admitted to the laboratory, 60 minutes after they are admitted to the laboratory and when they leave the laboratory, and their shivering level and temperature comfort perception will also be measured during these periods. In this form, the measurement times of body temperature values were determined based on the literature

    Time frame: 5 months

  2. Shivering level

    Tremor Level Diagnosis Form: The form, which Badjaita et al. (2008) determined the criteria by observation, determines the level of tremor according to the tremor in the extremities between 0 (no tremor) and 3 (severe tremor in the trunk, lower and upper extremities) points.

    Time frame: 5 months

  3. Thermal comfort perception

    Hypothermia Monitoring Form: It is a form in which body temperature, shivering level and temperature comfort perception of healthy volunteers are recorded. The body temperature of the healthy volunteers in the study and control groups will be measured when they are admitted to the basic skills laboratory, 15 minutes after they are admitted to the laboratory, 30 minutes after they are admitted to the laboratory, 60 minutes after they are admitted to the laboratory and when they leave the laboratory, and their shivering level and temperature comfort perception will also be measured during these periods. In this form, the measurement times of body temperature values were determined based on the literature

    Time frame: 5 months

  4. Descriptive Characteristics

    Descriptive Characteristics Form: The form created by the researcher in line with the literature consists of questions about descriptive characteristics of the voluntueers

    Time frame: 5 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Agarwal DK, Viers BR, Rivera ME, Nienow DA, Frank I, Tollefson MK, Gettman MT. Physical activity monitors can be successfully implemented to assess perioperative activity in urologic surgery. Mhealth. 2018 Sep 26;4:43. doi: 10.21037/mhealth.2018.09.05. eCollection 2018. PubMed 30363722 ↗
  • Badjatia N, Strongilis E, Gordon E, Prescutti M, Fernandez L, Fernandez A, Buitrago M, Schmidt JM, Ostapkovich ND, Mayer SA. Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale. Stroke. 2008 Dec;39(12):3242-7. doi: 10.1161/STROKEAHA.108.523654. Epub 2008 Oct 16. PubMed 18927450 ↗
  • Baskan, A., & Goncu-Berk, G. (2022). User Experience of Wearable Technologies: A Comparative Analysis of Textile-Based and Accessory-Based Wearable Products. Applied Sciences. 12(21), 11154. https://doi.org/10.3390/app122111154.
  • Bayoumy K, Gaber M, Elshafeey A, Mhaimeed O, Dineen EH, Marvel FA, Martin SS, Muse ED, Turakhia MP, Tarakji KG, Elshazly MB. Smart wearable devices in cardiovascular care: where we are and how to move forward. Nat Rev Cardiol. 2021 Aug;18(8):581-599. doi: 10.1038/s41569-021-00522-7. Epub 2021 Mar 4. PubMed 33664502 ↗
  • Burns A, Adeli H. Wearable technology for patients with brain and spinal cord injuries. Rev Neurosci. 2017 Nov 27;28(8):913-920. doi: 10.1515/revneuro-2017-0035. PubMed 28850551 ↗
  • Castellani JW, Young AJ. Human physiological responses to cold exposure: Acute responses and acclimatization to prolonged exposure. Auton Neurosci. 2016 Apr;196:63-74. doi: 10.1016/j.autneu.2016.02.009. Epub 2016 Feb 21. PubMed 26924539 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2025; primary completion for Jun 2026, 6 months later.

Of 132 non-industry interventional studies with no phase under Hypothermia, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 36. This study's planned 6 months is below that.

Counting every sponsor, half of 135 studies reached it within 16 months; a quarter within 6 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 21, 2024
First posted
Feb 28, 2024
StartEst.
Dec 15, 2025
Primary completionEst.
Jun 15, 2026
CompletionEst.
Sep 15, 2026
Last update
Sep 9, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06283771
Lead sponsor
Tarsus University
Collaborators
Mersin University
Responsible party
Gamze BOZKUL (Research Assistant, Tarsus University) — Principal investigator
First posted
Feb 28, 2024
Start date
Dec 15, 2025 (estimated)
Primary completion
Jun 15, 2026 (estimated)
Completion
Sep 15, 2026 (estimated)
Last update
Sep 9, 2025

Study contacts

Gülay Altun UĞRAŞ
Contact
gulay.altun@yahoo.com
0-324-3610001 ext. 14224
Gamze Bozkul
principal investigator · Tarsus University
Evren Değirmenci
principal investigator · Mersin University
Murat BOZLU
principal investigator · Mersin University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion